Marion McCourt

Marion McCourt

Corporate Officer/Principal at REGENERON PHARMACEUTICALS, INC.

Net worth: 9 M $ as of 2026-05-30

66 year
Health Technology
Consumer Services
Commercial Services

Profile

Marion McCourt currently works at Girls On The Run International, as Director and Regeneron Pharmaceuticals, Inc., as Executive Vice President-Commercial from 2021.
Ms. McCourt also formerly worked at AstraZeneca Canada, Inc., as President & Chief Executive Officer from 2011 to 2012, SCYNEXIS, Inc., as Independent Director from 2017 to 2018, CytomX Therapeutics, Inc., as Independent Director from 2017 to 2018, Amgen, Inc., as Vice President-US Commercial Operations from 2013 to 2016, AstraZeneca PLC, as Chief Operating Officer-United States Region from 2011 to 2013, AstraZeneca Pharmaceuticals LP, as Vice President-Managed Markets & Government, Medivation LLC (California), as Chief Operating Officer in 2016, and Sio Gene Therapies, Inc., as President & Chief Operating Officer from 2017 to 2018.
Ms. McCourt received her undergraduate degree from Lafayette College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-12-08 14,546 ( 0.01% ) 9 M $ 2026-05-30

Marion McCourt active positions

CompaniesPositionStart
REGENERON PHARMACEUTICALS, INC. Corporate Officer/Principal 2018-02-11
Director/Board Member -

Former positions of Marion McCourt

CompaniesPositionEnd
SCYNEXIS, INC. Director/Board Member 2018-09-17
CYTOMX THERAPEUTICS, INC. Director/Board Member 2018-06-12
SIO GENE THERAPIES INC. President 2018-02-11
MEDIVATION INC Chief Operating Officer 2016-08-31
AMGEN INC. Corporate Officer/Principal 2015-12-31
See the detail of Marion McCourt's experience

Training of Marion McCourt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

56

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Marion McCourt